These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16985683)

  • 21. [How to select the best candidates for prostate biopsies? The role of traditional tools and contribution of new biomarkers in prostate cancer].
    Audenet F; Rouprêt M; Perrin P; de La Taille A
    Prog Urol; 2011 May; 21 Suppl 3():S88-92. PubMed ID: 21616446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA testing: an evolving relationship with prostate cancer screening.
    Constantinou J; Feneley MR
    Prostate Cancer Prostatic Dis; 2006; 9(1):6-13. PubMed ID: 16314892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men.
    Coric J; Mujic J; Kucukalic E; Ler D
    Open Biochem J; 2015; 9():34-6. PubMed ID: 26157519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From pro-prostate specific antigen, [-2]pro-prostate specific antigen to Beckman Coulter phi: the evolution of new biomarkers for early detection of prostatic carcinoma.
    Zhang MZ; Lu YP
    Chin Med J (Engl); 2012 May; 125(9):1643-9. PubMed ID: 22800836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [proPSA: a precursor of prostate-specific antigen, may improve the early diagnosis of prostate cancer].
    Sela BA; Doolman R
    Harefuah; 2011 May; 150(5):466-9, 489. PubMed ID: 21678645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.
    Chan TY; Mikolajczyk SD; Lecksell K; Shue MJ; Rittenhouse HG; Partin AW; Epstein JI
    Urology; 2003 Jul; 62(1):177-81. PubMed ID: 12837462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer.
    Mikolajczyk SD; Rittenhouse HG
    Keio J Med; 2003 Jun; 52(2):86-91. PubMed ID: 12862359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer.
    Payne H; Cornford P
    Urol Oncol; 2011; 29(6):593-601. PubMed ID: 20060331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconnoitring the status of prostate specific antigen and its role in women.
    Dash P
    Indian J Clin Biochem; 2015 Apr; 30(2):124-33. PubMed ID: 25883418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate specific antigen. Current clinical application and future prospects.
    Duskova K; Vesely S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):18-26. PubMed ID: 25277491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostate cancer].
    Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical usefulness of prostate specific antigen: update 1994.
    Partin AW; Oesterling JE
    J Urol; 1994 Nov; 152(5 Pt 1):1358-68. PubMed ID: 7523702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for prostate cancer: moving forward in the molecular era.
    Vlachaki A; Baltogiannis D; Batistatou A; Tsambalas S; V Simos Y; E Palatianou M; Vezyraki P; Ragos V; Tsiambas E; Giannakopoulos X; Peschos D
    J BUON; 2018; 23(5):1242-1248. PubMed ID: 30570843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
    Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ
    Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic specific antigen for prostate cancer detection.
    Nogueira L; Corradi R; Eastham JA
    Int Braz J Urol; 2009; 35(5):521-9; discussion 530-2. PubMed ID: 19860930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate-specific antigen screening: pro.
    Loeb S; Catalona WJ
    Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.
    Krause BJ; Souvatzoglou M; Tuncel M; Herrmann K; Buck AK; Praus C; Schuster T; Geinitz H; Treiber U; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):18-23. PubMed ID: 17891394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen: critical issues for the practicing physician.
    Ruckle HC; Klee GG; Oesterling JE
    Mayo Clin Proc; 1994 Jan; 69(1):59-68. PubMed ID: 7505869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.